Publication Type:

Journal Article

Source:

Research Journal of Pharmaceutical, Biological and Chemical Sciences, Research Journal of Pharmaceutical, Biological and Chemical Sciences, Volume 7, Number 6, p.1098-1105 (2016)

URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84997017322&partnerID=40&md5=e59c6ce52c67bf4d82c2ad8d6d2484a1

Abstract:

<p>Diabetes Mellitus is an assorted group of metabolic disorders due to the inability of pancreas to secrete insulin or the insensitivity of the cells to insulin. This work has been chosen considering the vital role of aldose reductase inhibitors in Diabetes Mellitus through the polyol pathway. Consequently an effective cont rol is the key to tackle this abnormal condition. In silico analysis for the development of aldose reductase inhibitors were carried out using both phytochemicals and generation of new lead molecules as ligands. The phytochemicals selected for the study were Allicin, Galegine, Rhamnoside, Quercetin, Trigonelline and Ferulic Acid. The lead molecule nucleus finalized were that of chromenes and indole derivatives. The present study included the analysis of parameters relating to proteins such as primary and s econdary structure analysis, subcellular location, analysis of cavities, ADME as well as docking results. Positive results were shown by Allicin, Galegine, Rhamnoside, Quercetin, Trigonelline and Ferulic Acid when compared with the standard drugs like Epalrest and Sorbinil. The lead molecules of chromeme derivative AR2,methyl2,2-dimethyl3-(4oxo-3-phenoxymethyl)-4H-chromrn-8-yl)propanoate and indole derivative AR7, methylidene(([1-(phenoxymethyl)-2,3-dihydro-1H-indol-5yl]oxy))amine screened displayed significant results over the phytochemicals and the standard drugs used. Further in vitro pharmacological activities might prove to be useful to substantiate the results.</p>

Notes:

cited By 0

Cite this Research Publication

V. Vishnu, .T.S, S., and Asha Asokan Manakadan, “In silico strategy for designing of novel chromene and indole derivatives to combat diabetes mellitus”, Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 7, pp. 1098-1105, 2016.

207
PROGRAMS
OFFERED
5
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS
  • Amrita on Social Media

  • Contact us

    Amrita Vishwa Vidyapeetham
    Amritanagar, Coimbatore - 641 112
    Tamilnadu, India
    • Fax: +91-422-2686274
    • Coimbatore : +91 (422) 2685000
    • Amritapuri   : +91 (476) 280 1280
    • Bengaluru    : +91 (080) 251 83700
    • Kochi              : +91 (484) 280 1234
    • Mysuru          : +91 (821) 234 3479
    • Contact Details »